2026 Biomarker Research Fund (BRF)
Meet our BRF 2026 awardees.
Chosen for their vision. Funded for their potential. Prima Nexus is proud to stand behind the next generation of Malaysian biomarker researchers.
ClosedBRF 2.0 has closed. RM150,000 in research support reached 67 researchers.
Tap a poster to see it full size.
Prima Nexus
2026 Prima Nexus Biomarker Research Fund (BRF): Full Fund Allocation
The 2026 BRF has successfully allocated its full funding of RM150,000, providing complimentary biomarker ELISA kits to support eligible research projects. The fund is now 100% allocated, marking the successful completion of the 2026 funding cycle.
- Researchers Funded67
- Biomarkers Funded116
- Days Left0 days
Fully funded
The BRF is growing.
Funded 10+ Research Institutions Across Malaysia
Klang Valley and Negeri Sembilan
Across Malaysia
Penang- Kelantan
Terengganu
Johor
Sabah
What the fund supported
The biomarkers our awardees studied
The Biomarker Research Fund is designed to support Malaysian researchers in running more without spending more. These are ten of the biomarkers BRF 2026 researchers studied.
- IL-6Inflammation
- TNF-αInflammation
- IL-1βInflammation
- MMP-9Tissue repair
- IL-10Immune balance
- CortisolStress hormone
- PCSK9Cholesterol
- C-peptideDiabetes
- Dengue IgGInfection
- IL-8Inflammation
The bigger the box, the more often it was studied. IL-6, TNF-α and IL-1β were studied most often.
Biomarker Partnership
Want to work with us on your next biomarker study?
Message our team on WhatsApp and we will tell you how a biomarker partnership works.
Biomarker Research Fund 2026
An initiative by Prima Nexus Sdn. Bhd. Supporting researchers, enabling discoveries
Thank you to every research group that applied. Planning your next biomarker study? Our team is happy to talk it through.